At the heart of Smilow Cancer Hospital and Yale Cancer Center, our commitment to safety, compassionate care, and research excellence will always remain.
Patient and Cancer Information
Yale Cancer Center is Connecticut's only cancer center designated as a Comprehensive Cancer Center by the National Cancer Institute- and one of only 57 in the nation. The significance of this designation has profound implications for those who choose Smilow Cancer Hospital as the place where they will be cared for and receive treatment for their cancer. National Cancer Institute cancer centers are national leaders in cancer research, prevention, detection, and treatment. This provides patients at Smilow Cancer Hospital with novel treatment options and expert care.
The delivery of cancer care is becoming ever more complex, involving multiple disciplines for the diagnosis and treatment of patients. In response, Smilow Cancer Hospital and Yale Cancer Center have developed 13 multidisciplinary clinical centers to care for patients diagnosed with cancer. The clinical centers allow physicians and specialists at Smilow Cancer Hospital to focus their expertise on specific types of cancers enabling them to provide superior care to our patients through a patient-friendly system of care led by a nurse coordinator. Our nationally recognized physicians provide unparalleled cancer expertise and are leaders in both the treatment of cancers and the development of innovative treatment strategies.
The key characteristics of the 13 Clinical Centers at Smilow Cancer Hospital are:
- Patient centered care
- Rapid access to appointments and relevant tests
- Personalized care led by a physician in collaboration with a team of specialists
- Personal communication and assistance from a dedicated intake specialist and nurse coordinator
- Compassion and support for the psychological aspects of cancer
- Rapid communication with and involvement of outside primary care and referring physicians
Ways to stay safe during chemotherapy and immunotherapy.
Latest News
Copy Link
- January 13, 2026
Tumor Microenvironments, Target Antigens & Immunotherapy
- January 12, 2026
How Exercise Slows Tumor Growth
- January 12, 2026
Fall 2025 Spark Award Recipients Announced
- January 12, 2026
Dr. Alain Mina Joins Hematology Program at Smilow Cancer Hospital
- January 09, 2026
Pioneering Breast Cancer Research at Yale Cancer Center
- January 08, 2026
Yale-Led Study Identifies a New Target for Treating Acute Leukemia
- January 07, 2026Source: YouTube
The Power Behind an NCI-Designated Comprehensive Cancer Center
- January 06, 2026Source: Yale News
Office Hours: Getting to Know… Blair McNamara
- January 05, 2026Source: New England Journal of Medicine (Yale's Dr. Roy Herbst)
Navigating the Evolving Landscape of EGFR-Mutated NSCLC
- January 02, 2026Source: CURE Online
Gastric Cancer Care Evolves With Precision Oncology and New Therapies
- December 23, 2025
Kong Elected 2026 Fellow of the Society for Research on Nicotine and Tobacco
- December 22, 2025
Yale Launches New Street Medicine Training Program for Residents